{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer's disease", "Cognition", "Herbs", "Randomized clinical trial"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35960461", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "18"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.1007/s11011-022-01063-9"], "Journal": {"ISSN": "1573-7365", "JournalIssue": {"Volume": "38", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Jan"}}, "Title": "Metabolic brain disease", "ISOAbbreviation": "Metab Brain Dis"}, "ArticleTitle": "Natural remedies for Alzheimer's disease: A systematic review of randomized controlled trials.", "Pagination": {"StartPage": "17", "EndPage": "44", "MedlinePgn": "17-44"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is the common type of dementia and is currently incurable. Existing FDA-approved AD drugs may not be effective for everyone, they cannot cure the disease nor stop its progression and their effects diminish over time. Therefore, the present review aimed to explore the role of natural alternatives in the treatment of AD. A systematic search was conducted using Ovid MEDLINE, CINAHL, Cochrane and PubMed databases and reference lists up to November 30, 2021. Only randomized control trials were included and appraised using the National Institute of Health framework. Data analysis showed that herbs like Gingko Biloba, Melissa Officinalis, Salvia officinalis, Ginseng and saffron alone or in combination with curcumin, low-fat diet, NuAD-Trail, and soy lecithin showed significant positive effects on AD. Moreover, combination of natural and pharmaceuticals has far better effects than only allopathic treatment. Thus, different herbal remedies in combination with FDA approved drugs are effective and more promising in treatment of AD."], "CopyrightInformation": "\u00a9 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature."}, "AuthorList": [{"Identifier": ["0000-0002-2856-4022"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan. saara_ahmad@hotmail.com."}], "LastName": "Ahmad", "ForeName": "Saara", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Geriatrics, Monash University, Melbourne, Australia."}], "LastName": "Ahmed", "ForeName": "Saad Bilal", "Initials": "SB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan."}], "LastName": "Khan", "ForeName": "Asra", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan."}], "LastName": "Wasim", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of Karachi, Karachi, Pakistan."}, {"Identifier": [], "Affiliation": "Department of Biosciences, Shaheed Zulfiqar Ali Bhutto Institute of Science and Technology (SZABIST), Karachi, Pakistan."}], "LastName": "Tabassum", "ForeName": "Saiqa", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of Karachi, Karachi, Pakistan."}], "LastName": "Haider", "ForeName": "Saida", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, Liaquat National Hospital, Karachi, Pakistan."}], "LastName": "Ahmed", "ForeName": "Fatima", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan."}], "LastName": "Batool", "ForeName": "Zehra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Federal Urdu University of Science and Technology, Karachi, Pakistan."}], "LastName": "Khaliq", "ForeName": "Saima", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan."}], "LastName": "Rafiq", "ForeName": "Hamna", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan."}], "LastName": "Tikmani", "ForeName": "Prashant", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan."}], "LastName": "Gilani", "ForeName": "Anwar-Ul-Hassan", "Initials": "AU"}], "PublicationTypeList": ["Journal Article", "Review", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Metab Brain Dis", "NlmUniqueID": "8610370", "ISSNLinking": "0885-7490"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Randomized Controlled Trials as Topic"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ahmed T, Gilani AH (2014) Therapeutic potential of turmeric in Alzheimer\u2019s disease: curcumin or curcuminoids? Phytother Res 28(4):517\u2013525. https://doi.org/10.1002/ptr.5030", "ArticleIdList": ["10.1002/ptr.5030"]}, {"Citation": "Ahmed T, Gilani AU, Abdollahi M, Daglia M, Nabavi SF, Nabavi SM (2015) Berberine and neurodegeneration: A review of literature. Pharmacol Rep 67(5):970\u2013979. https://doi.org/10.1016/j.pharep.2015.03.002", "ArticleIdList": ["10.1016/j.pharep.2015.03.002"]}, {"Citation": "Akhondzadeh S, Abbasi SH (2006) Herbal medicine in the treatment of Alzheimer\u2019s disease. Am J Alzheimers Dis Other Demen 21(2):113\u2013118. https://doi.org/10.1177/153331750602100211", "ArticleIdList": ["10.1177/153331750602100211"]}, {"Citation": "Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M (2003) Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer\u2019s disease: a double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 28(1):53\u201359. https://doi.org/10.1046/j.1365-2710.2003.00463.x", "ArticleIdList": ["10.1046/j.1365-2710.2003.00463.x"]}, {"Citation": "Akhondzadeh S, Sabet MS, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi S, Yousefi MH, Alimardani R, Jamshidi A, Zare F, Moradi A (2010a) Saffron in the treatment of patients with mild to moderate Alzheimer\u2019s disease: a 16-week, randomized and placebo-controlled trial. J Clin Pharm Ther 35(5):581\u2013588. https://doi.org/10.1111/j.1365-2710.2009.01133.x", "ArticleIdList": ["10.1111/j.1365-2710.2009.01133.x"]}, {"Citation": "Akhondzadeh S, Shafiee Sabet M, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SS, Yousefi MH, Alimardani R, Jamshidi A, Rezazadeh SA, Yousefi A, Zare F, Moradi A, Vossoughi A (2010b) A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer\u2019s disease. Psychopharmacology 207(4):637\u2013643. https://doi.org/10.1007/s00213-009-1706-1", "ArticleIdList": ["10.1007/s00213-009-1706-1"]}, {"Citation": "Ali TB, Schleret TR, Reilly BM, Chen WY, Abagyan R (2015) Adverse effects of cholinesterase inhibitors in dementia, according to the pharmacovigilance databases of the United-States and Canada. PLoS ONE 10(12):e0144337. https://doi.org/10.1371/journal.pone.0144337", "ArticleIdList": ["10.1371/journal.pone.0144337"]}, {"Citation": "Andrieu S, Ousset PJ, Coley N, Ouzid M, Mathiex-Fortunet H, Vellas B, G GuidAge study (2008) GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer\u2019s disease in elderly subjects with memory complaints. i. rationale, design and baseline data. Curr Alzheimer Res 5(4):406\u2013415. https://doi.org/10.2174/156720508785132271", "ArticleIdList": ["10.2174/156720508785132271"]}, {"Citation": "Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Walter BK, Tsai E, Plymate SR, Postupna N, Wilkinson CW, Zhang J, Lampe J, Kahn SE, Craft S (2011) Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch Neurol 68(6):743\u2013752. https://doi.org/10.1001/archneurol.2011.125", "ArticleIdList": ["10.1001/archneurol.2011.125"]}, {"Citation": "Beatty S, Chakravarthy U, Nolan JM, Muldrew KA, Woodside JV, Denny F, Stevenson MR (2013) Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology 120(3):600\u2013606. https://doi.org/10.1016/j.ophtha.2012.08.040", "ArticleIdList": ["10.1016/j.ophtha.2012.08.040"]}, {"Citation": "Bhatti AB, Usman M, Ali F, Satti SA (2016) Vitamin supplementation as an adjuvant treatment for Alzheimer\u2019s disease. J Clin Diagn Res 10(8):OE07"}, {"Citation": "Birks J, Grimley Evans J (2009) Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev (1): CD003120. https://doi.org/10.1002/14651858.CD003120.pub3"}, {"Citation": "Brown MA, Sampson EL, Jones L, Barron AM (2013) Prognostic indicators of 6-month mortality in elderly people with advanced dementia: a systematic review. Palliat Med 27(5):389\u2013400. https://doi.org/10.1177/0269216312465649", "ArticleIdList": ["10.1177/0269216312465649"]}, {"Citation": "Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Moller HJ, Rogers SL, Friedhoff LT (1999) The effects of donepezil in Alzheimer\u2019s disease - results from a multinational trial. Dement Geriatr Cogn Disord 10(3):237\u2013244. https://doi.org/10.1159/000017126", "ArticleIdList": ["10.1159/000017126"]}, {"Citation": "Cansev M, Wurtman RJ, Sakamoto T, Ulus IH (2008) Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimers Dement 4(1 Suppl 1):S153-168. https://doi.org/10.1016/j.jalz.2007.10.005", "ArticleIdList": ["10.1016/j.jalz.2007.10.005"]}, {"Citation": "Carver AD, Dobson AM (1995) Effects of dietary supplementation of elderly demented hospital residents. J Hum Nutr Diet 8(6):389\u2013394", "ArticleIdList": ["10.1111/j.1365-277X.1995.tb00334.x"]}, {"Citation": "Celik IE, Acar B, Cay S (2015) An unusual cardiovascular adverse effect of donepezil. Intern Med J 45(8):877\u2013878. https://doi.org/10.1111/imj.12827", "ArticleIdList": ["10.1111/imj.12827"]}, {"Citation": "Cummings J, Scheltens P, McKeith I, Blesa R, Harrison JE, Bertolucci PH, Rockwood K, Wilkinson D, Wijker W, Bennett DA, Shah RC (2017) Effect size analyses of Souvenaid in patients with Alzheimer\u2019s disease. J Alzheimers Dis 55(3):1131\u20131139. https://doi.org/10.3233/JAD-160745", "ArticleIdList": ["10.3233/JAD-160745"]}, {"Citation": "Cummings JL, Mackell J, Kaufer D (2008) Behavioral effects of current Alzheimer\u2019s disease treatments: a descriptive review. Alzheimers Dement 4(1):49\u201360. https://doi.org/10.1016/j.jalz.2007.10.011", "ArticleIdList": ["10.1016/j.jalz.2007.10.011"]}, {"Citation": "Custodio N, Wheelock A, Thumala D, Slachevsky A (2017) Dementia in Latin America: Epidemiological evidence and implications for public policy. Front Aging Neurosci 9:221. https://doi.org/10.3389/fnagi.2017.00221", "ArticleIdList": ["10.3389/fnagi.2017.00221"]}, {"Citation": "de Waal H, Stam CJ, Lansbergen MM, Wieggers RL, Kamphuis PJ, Scheltens P, Maestu F, van Straaten EC (2014) The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer\u2019s disease: a randomised controlled study. PLoS ONE 9(1):e86558. https://doi.org/10.1371/journal.pone.0086558", "ArticleIdList": ["10.1371/journal.pone.0086558"]}, {"Citation": "DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, Lopez OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD, I. Ginkgo Evaluation of Memory Study (2008) Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 300(19):2253\u20132262. https://doi.org/10.1001/jama.2008.683", "ArticleIdList": ["10.1001/jama.2008.683"]}, {"Citation": "Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M (2013) A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer\u2019s disease. J Alzheimers Dis 35(2):349\u2013361. https://doi.org/10.3233/JAD-122140", "ArticleIdList": ["10.3233/JAD-122140"]}, {"Citation": "Farokhnia M, ShafieeSabet M, Iranpour N, Gougol A, Yekehtaz H, Alimardani R, Farsad F, Kamalipour M, Akhondzadeh S (2014) Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer\u2019s disease: a double-blind randomized clinical trial. Hum Psychopharmacol 29(4):351\u2013359. https://doi.org/10.1002/hup.2412", "ArticleIdList": ["10.1002/hup.2412"]}, {"Citation": "Finder VH, Vodopivec I, Nitsch RM, Glockshuber R (2010) The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42. J Mol Biol 396(1):9\u201318. https://doi.org/10.1016/j.jmb.2009.12.016", "ArticleIdList": ["10.1016/j.jmb.2009.12.016"]}, {"Citation": "Finley JW, Gao S (2017) A perspective on Crocus sativus L. (Saffron) constituent Crocin: A potent water-soluble antioxidant and potential therapy for Alzheimer\u2019s disease. J Agric Food Chem 65(5):1005\u20131020. https://doi.org/10.1021/acs.jafc.6b04398", "ArticleIdList": ["10.1021/acs.jafc.6b04398"]}, {"Citation": "Fortier M, Castellano CA, St-Pierre V, Myette-Cote E, Langlois F, Roy M, Morin MC, Bocti C, Fulop T, Godin JP, Delannoy C, Cuenoud B, Cunnane SC (2021) A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT. Alzheimers Dement 17(3):543\u2013552. https://doi.org/10.1002/alz.12206", "ArticleIdList": ["10.1002/alz.12206"]}, {"Citation": "Fu LM, Li JT (2011) A systematic review of single chinese herbs for Alzheimer\u2019s disease treatment. Evid Based Complement Alternat Med 2011:640284. https://doi.org/10.1093/ecam/nep136", "ArticleIdList": ["10.1093/ecam/nep136"]}, {"Citation": "Gilani AH, Rahman AU (2005) Trends in ethnopharmocology. J Ethnopharmacol 100(1\u20132):43\u201349. https://doi.org/10.1016/j.jep.2005.06.001", "ArticleIdList": ["10.1016/j.jep.2005.06.001"]}, {"Citation": "Giulietti A, Vignini A, Nanetti L, Mazzanti L, Di Primio R, Salvolini E (2016) Alzheimer\u2019s disease risk and progression: The role of nutritional supplements and their effect on drug therapy outcome. Curr Neuropharmacol 14(2):177\u2013190. https://doi.org/10.2174/1570159x13666150928155321", "ArticleIdList": ["10.2174/1570159x13666150928155321"]}, {"Citation": "Guzman-Martinez L, Farias GA, Tapia JP, Sanchez MP, Fuentes P, Gloger S, Maccioni RB (2021) Interventional study to evaluate the clinical effects and safety of the nutraceutical compound BrainUp-10(R) in a Cohort of patients with Alzheimer\u2019s disease: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial. J Alzheimers Dis 81(3):1231\u20131241. https://doi.org/10.3233/JAD-201501", "ArticleIdList": ["10.3233/JAD-201501"]}, {"Citation": "Hewlings SJ, Kalman DS (2017) Curcumin: A review of its effects on human health. Foods 6(10). https://doi.org/10.3390/foods6100092"}, {"Citation": "Hoerr R (2005) Treatment effects of EGb 761 and cholinesterase inhibitors\u2013why available studies do not demonstrate superiority of the latter. Phytomedicine 12(8):598\u2013600. https://doi.org/10.1016/j.phymed.2004.06.020", "ArticleIdList": ["10.1016/j.phymed.2004.06.020"]}, {"Citation": "Hogan DB, Goldlist B, Naglie G, Patterson C (2004) Comparison studies of cholinesterase inhibitors for Alzheimer\u2019s disease. Lancet Neurol 3(10):622\u2013626. https://doi.org/10.1016/S1474-4422(04)00883-X", "ArticleIdList": ["10.1016/S1474-4422(04)00883-X"]}, {"Citation": "Holguin S, Martinez J, Chow C, Wurtman R (2008) Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J 22(11):3938\u20133946. https://doi.org/10.1096/fj.08-112425", "ArticleIdList": ["10.1096/fj.08-112425"]}, {"Citation": "Hosseinzadeh H, Ziaee T, Sadeghi A (2008) The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats. Phytomedicine 15(6\u20137):491\u2013495. https://doi.org/10.1016/j.phymed.2007.09.020", "ArticleIdList": ["10.1016/j.phymed.2007.09.020"]}, {"Citation": "Ihl R, Grass-Kapanke B, Janner M, Weyer G (1999) Neuropsychometric tests in cross sectional and longitudinal studies - a regression analysis of ADAS - cog. SKT and MMSE Pharmacopsychiatry 32(6):248\u2013254. https://doi.org/10.1055/s-2007-991102", "ArticleIdList": ["10.1055/s-2007-991102"]}, {"Citation": "Jansen D, Zerbi V, Arnoldussen IA, Wiesmann M, Rijpma A, Fang XT, Dederen PJ, Mutsaers MP, Broersen LM, Lutjohann D, Miller M, Joosten LA, Heerschap A, Kiliaan AJ (2013) Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AbetaPPswe-PS1dE9 mice. PLoS ONE 8(9):e75393. https://doi.org/10.1371/journal.pone.0075393", "ArticleIdList": ["10.1371/journal.pone.0075393"]}, {"Citation": "Kanowski S, Hoerr R (2003) Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry 36(6):297\u2013303. https://doi.org/10.1055/s-2003-45117", "ArticleIdList": ["10.1055/s-2003-45117"]}, {"Citation": "Karlawish J (2014) How are we going to live with Alzheimer\u2019s disease? Health Aff 33(4):541\u2013546", "ArticleIdList": ["10.1377/hlthaff.2014.0089"]}, {"Citation": "Kell G, Rao A, Beccaria G, Clayton P, Inarejos-Garcia AM, Prodanov M (2017) affron((R)) a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial. Complement Ther Med 33:58\u201364. https://doi.org/10.1016/j.ctim.2017.06.001", "ArticleIdList": ["10.1016/j.ctim.2017.06.001"]}, {"Citation": "Konrath EL, Passos Cdos S, Klein LC Jr, Henriques AT (2013) Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer\u2019s disease. J Pharm Pharmacol 65(12):1701\u20131725. https://doi.org/10.1111/jphp.12090", "ArticleIdList": ["10.1111/jphp.12090"]}, {"Citation": "Kurz A, Van Baelen B (2004) Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration. Dement Geriatr Cogn Disord 18(2):217\u2013226. https://doi.org/10.1159/000079388", "ArticleIdList": ["10.1159/000079388"]}, {"Citation": "Leinonen A, Koponen M, Hartikainen S (2015) Systematic review: Representativeness of participants in RCTs of acetylcholinesterase inhibitors. PLoS ONE 10(5):e0124500. https://doi.org/10.1371/journal.pone.0124500", "ArticleIdList": ["10.1371/journal.pone.0124500"]}, {"Citation": "Leung JG (2014) Donepezil-induced mania. Consult Pharm 29(3):191\u2013195. https://doi.org/10.4140/TCP.n.2014.191", "ArticleIdList": ["10.4140/TCP.n.2014.191"]}, {"Citation": "Liu X, Hao W, Qin Y, Decker Y, Wang X, Burkart M, Schotz K, Menger MD, Fassbender K, Liu Y (2015) Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer\u2019s disease. Brain Behav Immun 46:121\u2013131. https://doi.org/10.1016/j.bbi.2015.01.011", "ArticleIdList": ["10.1016/j.bbi.2015.01.011"]}, {"Citation": "Liu X, Teng Z, Cui C, Wang R, Liu M, Zhang Y (2014) Amyloid beta-derived diffusible ligands (ADDLs) induce abnormal expression of insulin receptors in rat hippocampal neurons. J Mol Neurosci 52(1):124\u2013130. https://doi.org/10.1007/s12031-013-0216-0", "ArticleIdList": ["10.1007/s12031-013-0216-0"]}, {"Citation": "Lopresti AL, Drummond PD (2014) Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Hum Psychopharmacol 29(6):517\u2013527. https://doi.org/10.1002/hup.2434", "ArticleIdList": ["10.1002/hup.2434"]}, {"Citation": "Lopresti AL, Drummond PD (2017) Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study. J Affect Disord 207:188\u2013196. https://doi.org/10.1016/j.jad.2016.09.047", "ArticleIdList": ["10.1016/j.jad.2016.09.047"]}, {"Citation": "Man SC, Durairajan SS, Kum WF, Lu JH, Huang JD, Cheng CF, Chung V, Xu M, Li M (2008) Systematic review on the efficacy and safety of herbal medicines for Alzheimer\u2019s disease. J Alzheimers Dis 14(2):209\u2013223. https://doi.org/10.3233/jad-2008-14209", "ArticleIdList": ["10.3233/jad-2008-14209"]}, {"Citation": "Maurer K, Ihl R, Dierks T, Frolich L (1997) Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res 31(6):645\u2013655. https://doi.org/10.1016/s0022-3956(97)00022-8", "ArticleIdList": ["10.1016/s0022-3956(97)00022-8"]}, {"Citation": "Mayeux R, Stern Y (2012) Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med 2(8). https://doi.org/10.1101/cshperspect.a006239"}, {"Citation": "Mazidi M, Shemshian M, Mousavi SH, Norouzy A, Kermani T, Moghiman T, Sadeghi A, Mokhber N, Ghayour-Mobarhan M, Ferns GA (2016) A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression. J Complement Integr Med 13(2):195\u2013199. https://doi.org/10.1515/jcim-2015-0043", "ArticleIdList": ["10.1515/jcim-2015-0043"]}, {"Citation": "Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142(1):37\u201346. https://doi.org/10.7326/0003-4819-142-1-200501040-00110", "ArticleIdList": ["10.7326/0003-4819-142-1-200501040-00110"]}, {"Citation": "Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264\u2013269, W264. https://doi.org/10.7326/0003-4819-151-4-200908180-00135", "ArticleIdList": ["10.7326/0003-4819-151-4-200908180-00135"]}, {"Citation": "More MI, Freitas U, Rutenberg D (2014) Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer\u2019s disease and dementia. Adv Ther 31(12):1247\u20131262. https://doi.org/10.1007/s12325-014-0165-1", "ArticleIdList": ["10.1007/s12325-014-0165-1"]}, {"Citation": "Morley JE (2010) Nutrition and the brain. Clin Geriatr Med 26(1):89\u201398. https://doi.org/10.1016/j.cger.2009.11.005", "ArticleIdList": ["10.1016/j.cger.2009.11.005"]}, {"Citation": "Moshiri M, Vahabzadeh M, Hosseinzadeh H (2015) Clinical applications of Saffron (Crocus sativus) and its constituents: A review. Drug Res (stuttg) 65(6):287\u2013295. https://doi.org/10.1055/s-0034-1375681", "ArticleIdList": ["10.1055/s-0034-1375681"]}, {"Citation": "Napryeyenko O, Borzenko I, G-N S Group (2007) Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial. Arzneimittelforschung 57(1):4\u201311. https://doi.org/10.1055/s-0031-1296579", "ArticleIdList": ["10.1055/s-0031-1296579"]}, {"Citation": "Nasab NM, Bahrammi MA, Nikpour MR, Rahim F, Naghibis SN (2012) Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer\u2019s dementia. J Pak Med Assoc 62(7):677\u2013680"}, {"Citation": "Nolan JM, Loskutova E, Howard A, Mulcahy R, Moran R, Stack J, Bolger M, Coen RF, Dennison J, Akuffo KO, Owens N, Power R, Thurnham D, Beatty S (2015) The impact of supplemental macular carotenoids in Alzheimer\u2019s disease: a randomized clinical trial. J Alzheimers Dis 44(4):1157\u20131169. https://doi.org/10.3233/JAD-142265", "ArticleIdList": ["10.3233/JAD-142265"]}, {"Citation": "Noori T, Dehpour AR, Sureda A, Sobarzo-Sanchez E, Shirooie S (2021) Role of natural products for the treatment of Alzheimer\u2019s disease. Eur J Pharmacol 898:173974. https://doi.org/10.1016/j.ejphar.2021.173974", "ArticleIdList": ["10.1016/j.ejphar.2021.173974"]}, {"Citation": "Ohno K, Ito M, Ichihara M, Ito M (2012) Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases. Oxid Med Cell Longev 2012:353152. https://doi.org/10.1155/2012/353152", "ArticleIdList": ["10.1155/2012/353152"]}, {"Citation": "Phillips MCL, Deprez LM, Mortimer GMN, Murtagh DKJ, McCoy S, Mylchreest R, Gilbertson LJ, Clark KM, Simpson PV, McManus EJ, Oh JE, Yadavaraj S, King VM, Pillai A, Romero-Ferrando B, Brinkhuis M, Copeland BM, Samad S, Liao S, Schepel JAC (2021) Randomized crossover trial of a modified ketogenic diet in Alzheimer\u2019s disease. Alzheimers Res Ther 13(1):51. https://doi.org/10.1186/s13195-021-00783-x", "ArticleIdList": ["10.1186/s13195-021-00783-x"]}, {"Citation": "Pivi GA, da Silva RV, Juliano Y, Novo NF, Okamoto IH, Brant CQ, Bertolucci PH (2011) A prospective study of nutrition education and oral nutritional supplementation in patients with Alzheimer\u2019s disease. Nutr J 10:98. https://doi.org/10.1186/1475-2891-10-98", "ArticleIdList": ["10.1186/1475-2891-10-98"]}, {"Citation": "Puranen TM, Pitkala KH, Suominen MH (2015) Tailored nutritional guidance for home-dwelling AD families: the Feasibility of and Elements Promoting Positive Changes in Diet (NuAD-Trial). J Nutr Health Aging 19(4):454\u2013459. https://doi.org/10.1007/s12603-014-0567-4", "ArticleIdList": ["10.1007/s12603-014-0567-4"]}, {"Citation": "Qizilbash N, Birks J, Lopez-Arrieta J, Lewington S, Szeto S (2000) Tacrine for Alzheimer's disease. Cochrane Database Syst Rev (2):CD000202. https://doi.org/10.1002/14651858.CD000202"}, {"Citation": "Rainey-Smith SR, Brown BM, Sohrabi HR, Shah T, Goozee KG, Gupta VB, Martins RN (2016) Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults. Br J Nutr 115(12):2106\u20132113. https://doi.org/10.1017/S0007114516001203", "ArticleIdList": ["10.1017/S0007114516001203"]}, {"Citation": "Rakonczay Z (2003) Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer\u2019s disease brain. Acta Biol Hung 54(2):183\u2013189. https://doi.org/10.1556/ABiol.54.2003.2.7", "ArticleIdList": ["10.1556/ABiol.54.2003.2.7"]}, {"Citation": "Rijpma A, Meulenbroek O, van Hees AM, Sijben JW, Vellas B, Shah RC, Bennett DA, Scheltens P, Olde Rikkert MG (2015) Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer\u2019s disease. Alzheimers Res Ther 7(1):51. https://doi.org/10.1186/s13195-015-0134-1", "ArticleIdList": ["10.1186/s13195-015-0134-1"]}, {"Citation": "Rijpma A, van der Graaf M, Lansbergen MM, Meulenbroek O, Cetinyurek-Yavuz A, Sijben JW, Heerschap A, Olde Rikkert MGM (2017) The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer\u2019s disease: results from a randomized controlled trial. Alzheimers Res Ther 9(1):51. https://doi.org/10.1186/s13195-017-0286-2", "ArticleIdList": ["10.1186/s13195-017-0286-2"]}, {"Citation": "Rogers SL, Doody RS, Mohs RC, Friedhoff LT (1998) Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group Arch Intern Med 158(9):1021\u20131031. https://doi.org/10.1001/archinte.158.9.1021", "ArticleIdList": ["10.1001/archinte.158.9.1021"]}, {"Citation": "Salas-Salvado J, Torres M, Planas M, Altimir S, Pagan C, Gonzalez ME, Johnston S, Puiggros C, Bonada A, Garcia-Lorda P (2005) Effect of oral administration of a whole formula diet on nutritional and cognitive status in patients with Alzheimer\u2019s disease. Clin Nutr 24(3):390\u2013397. https://doi.org/10.1016/j.clnu.2004.12.006", "ArticleIdList": ["10.1016/j.clnu.2004.12.006"]}, {"Citation": "Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer\u2019s disease. Lancet 388(10043):505\u2013517. https://doi.org/10.1016/S0140-6736(15)01124-1", "ArticleIdList": ["10.1016/S0140-6736(15)01124-1"]}, {"Citation": "Scheltens P, Twisk JW, Blesa R, Scarpini E, von Arnim CA, Bongers A, Harrison J, Swinkels SH, Stam CJ, de Waal H, Wurtman RJ, Wieggers RL, Vellas B, Kamphuis PJ (2012) Efficacy of Souvenaid in mild Alzheimer\u2019s disease: results from a randomized, controlled trial. J Alzheimers Dis 31(1):225\u2013236. https://doi.org/10.3233/JAD-2012-121189", "ArticleIdList": ["10.3233/JAD-2012-121189"]}, {"Citation": "Scholfield C (1981) Composition of soybean lecithin. J Am Oil Chem Soc 58(10):889\u2013892", "ArticleIdList": ["10.1007/BF02659652"]}, {"Citation": "Sezgin Z, Dincer Y (2014) Alzheimer\u2019s disease and epigenetic diet. Neurochem Int 78:105\u2013116. https://doi.org/10.1016/j.neuint.2014.09.012", "ArticleIdList": ["10.1016/j.neuint.2014.09.012"]}, {"Citation": "Silva P, Kergoat MJ, Shatenstein B (2013) Challenges in managing the diet of older adults with early-stage Alzheimer dementia: a caregiver perspective. J Nutr Health Aging 17(2):142\u2013147. https://doi.org/10.1007/s12603-012-0385-5", "ArticleIdList": ["10.1007/s12603-012-0385-5"]}, {"Citation": "Soininen H, Solomon A, Visser PJ, Hendrix SB, Blennow K, Kivipelto M, Hartmann T, G. LipiDiDiet Clinical Study (2017) 24-month intervention with a specific multinutrient in people with prodromal Alzheimer\u2019s disease (LipiDiDiet): a randomised, double-blind, controlled trial. Lancet Neurol 16(12):965\u2013975. https://doi.org/10.1016/S1474-4422(17)30332-0", "ArticleIdList": ["10.1016/S1474-4422(17)30332-0"]}, {"Citation": "Soininen H, Solomon A, Visser PJ, Hendrix SB, Blennow K, Kivipelto M, Hartmann T, G. LipiDiDiet Clinical Study (2021) 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer\u2019s disease. Alzheimers Dement 17(1):29\u201340. https://doi.org/10.1002/alz.12172", "ArticleIdList": ["10.1002/alz.12172"]}, {"Citation": "Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R (2002) Ginkgo for memory enhancement: a randomized controlled trial. JAMA 288(7):835\u2013840. https://doi.org/10.1001/jama.288.7.835", "ArticleIdList": ["10.1001/jama.288.7.835"]}, {"Citation": "Tang M, Taghibiglou C (2017) The mechanisms of action of curcumin in Alzheimer\u2019s disease. J Alzheimers Dis 58(4):1003\u20131016. https://doi.org/10.3233/JAD-170188", "ArticleIdList": ["10.3233/JAD-170188"]}, {"Citation": "Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, G Memantine Study (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291(3):317\u2013324. https://doi.org/10.1001/jama.291.3.317", "ArticleIdList": ["10.1001/jama.291.3.317"]}, {"Citation": "Vellas B, Coley N, Ousset P-J, Berrut G, Dartigues J-F, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P (2012) Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer\u2019s disease (GuidAge): a randomised placebo-controlled trial. The Lancet Neurology 11(10):851\u2013859", "ArticleIdList": ["10.1016/S1474-4422(12)70206-5"]}, {"Citation": "Wang J, Gu BJ, Masters CL, Wang YJ (2017) A systemic view of Alzheimer disease - insights from amyloid-beta metabolism beyond the brain. Nat Rev Neurol 13(10):612\u2013623. https://doi.org/10.1038/nrneurol.2017.111", "ArticleIdList": ["10.1038/nrneurol.2017.111"]}, {"Citation": "Wettstein A (2000) Cholinesterase inhibitors and Gingko extracts\u2013are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months\u2019 duration. Phytomedicine 6(6):393\u2013401", "ArticleIdList": ["10.1016/S0944-7113(00)80066-5"]}, {"Citation": "Wightman EL (2017) Potential benefits of phytochemicals against Alzheimer\u2019s disease. Proc Nutr Soc 76(2):106\u2013112. https://doi.org/10.1017/S0029665116002962", "ArticleIdList": ["10.1017/S0029665116002962"]}, {"Citation": "Wurtman RJ, Cansev M, Sakamoto T, Ulus IH (2009) Use of phosphatide precursors to promote synaptogenesis. Annu Rev Nutr 29:59\u201387", "ArticleIdList": ["10.1146/annurev-nutr-080508-141059"]}, {"Citation": "Yancheva S, Ihl R, Nikolova G, Panayotov P, Schlaefke S, Hoerr R, G S Group (2009) Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer\u2019s disease with neuropsychiatric features: a randomised, double-blind, exploratory trial. Aging Ment Health 13(2):183\u2013190. https://doi.org/10.1080/13607860902749057", "ArticleIdList": ["10.1080/13607860902749057"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "6", "Day": "3"}, {"Year": "2022", "Month": "7", "Day": "29"}, {"Year": "2022", "Month": "8", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "12", "Hour": "11", "Minute": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35960461", "10.1007/s11011-022-01063-9", "10.1007/s11011-022-01063-9"]}}], "PubmedBookArticle": []}